I agree, I don't like the spin off model, for that exact reason. Benefits can be hidden and diluted. Look at what happened with Phoremost. They got a lot of IP and we got Jack... That's not to say you don't ring fence risk through multiple entities, etc... that's just basic risk management...but spin-off's can be very bad for LT shareholders. As always, the devil is in the detail...which was not provided. That and the lack of $'s as part of the deal doesn't excite me as a shareholder. I like it, but it a ways off yet before there is a benefit. What did the market think of it?
- Forums
- ASX - By Stock
- PYC
- Ann: Strategic Partnership and Lead Program
PYC
pyc therapeutics limited
Add to My Watchlist
0.40%
!
$1.27

Ann: Strategic Partnership and Lead Program, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M |
Open | High | Low | Value | Volume |
$1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 1380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13987 | 1.265 |
2 | 16380 | 1.260 |
3 | 14380 | 1.255 |
3 | 103380 | 1.250 |
1 | 4000 | 1.225 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 1380 | 1 |
1.290 | 27010 | 3 |
1.295 | 25880 | 2 |
1.300 | 59168 | 4 |
1.325 | 9001 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online